Inhibition of hepatitis C virus infection by NS5A-specific aptamer
文献类型:期刊论文
作者 | Yu, Xiaoyan1; Gao, Yimin1; Xue, Binbin1; Wang, Xiaohong1; Yang, Darong1,2; Qin, Yuwen1; Yu, Rong1; Liu, Nianli1,2; Xu, Li3; Fang, Xiaohong3 |
刊名 | ANTIVIRAL RESEARCH |
出版日期 | 2014-06-01 |
卷号 | 106页码:116-124 |
ISSN号 | 0166-3542 |
关键词 | Hcv Ns5a Aptamer Antivirals Replication Mutation |
DOI | 10.1016/j.antiviral.2014.03.020 |
英文摘要 | To increase efficacy of hepatitis C treatment, future regiments will incorporate multiple direct-acting antiviral drugs. HCV NS5A protein was expressed and purified. Aptamers against NS5A were screened and obtained by the selective evolution of ligands by exponential enrichment approach and the antiviral actions of the aptamers were tested. The mechanisms through which the aptamers exert their antiviral activity were explored. The aptamers NS5A-4 and NS5A-5 inhibit HCV RNA replication and infectious virus production without causing cytotoxicity in human hepatocytes. The aptamers do not affect hepatitis B virus replication in HepG2.2.15 cells. Interferon beta (IFN-beta) and interferon-stimulated genes (ISGs) are not induced by the aptamers in HCV-infected hepatocytes. Further study shows that domain I and domain III of NS5A protein are involved in the suppression of HCV RNA replication and infectious virus production by NS5A-4. Y2105H within NS5A is the major resistance mutation identified. NS5A aptamer disrupts the interaction of NS5A with core protein. The data suggest that the aptamers against NS5A protein may exert antiviral effects through inhibiting viral RNA replication, preventing the interaction of NS5A with core protein. Aptamers for NS5A may be used to understand the mechanisms of virus replication and assembly and served as potential therapeutic agents for hepatitis C. (C) 2014 Elsevier B.V. All rights reserved. |
语种 | 英语 |
出版者 | ELSEVIER SCIENCE BV |
WOS记录号 | WOS:000336827700015 |
源URL | [http://ir.iccas.ac.cn/handle/121111/50123] |
专题 | 中国科学院化学研究所 |
通讯作者 | Zhu, Haizhen |
作者单位 | 1.Hunan Univ, State Key Lab Chemo Biosensing & Chemometr, Dept Mol Med, Changsha 410082, Hunan, Peoples R China 2.Cent S Univ, Affiliated Tumor Hosp, Xiangya Med Sch,Res Ctr Canc Prevent & Treatment, Hunan Prov Tumor Hosp,Translat Med Res Ctr Liver, Changsha, Hunan, Peoples R China 3.Chinese Acad Sci, Inst Chem, Key Lab Mol Nanostruct & Nanotechnol, Beijing 100080, Peoples R China |
推荐引用方式 GB/T 7714 | Yu, Xiaoyan,Gao, Yimin,Xue, Binbin,et al. Inhibition of hepatitis C virus infection by NS5A-specific aptamer[J]. ANTIVIRAL RESEARCH,2014,106:116-124. |
APA | Yu, Xiaoyan.,Gao, Yimin.,Xue, Binbin.,Wang, Xiaohong.,Yang, Darong.,...&Zhu, Haizhen.(2014).Inhibition of hepatitis C virus infection by NS5A-specific aptamer.ANTIVIRAL RESEARCH,106,116-124. |
MLA | Yu, Xiaoyan,et al."Inhibition of hepatitis C virus infection by NS5A-specific aptamer".ANTIVIRAL RESEARCH 106(2014):116-124. |
入库方式: OAI收割
来源:化学研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。